Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1500 participants
OBSERVATIONAL
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical Outcomes Database For Faculty of Hepatopancreatic Biliary Surgery
NCT01657383
Endoscopic Drainage of Collections After Pancreatic Surgery
NCT02909296
METabolomic and Immune PROfiling in the Development of Pancreatic Fistulas After cepHalic duodEnopancreatectomy
NCT06283160
Pancreaticoduodenectomies With Complete Arterial Coverage by Retromesenteric Omentoplasty
NCT05992857
Predictors of Severity of Postoperative Pancreatic Fistula After Pancreatoduodenectomy
NCT05291923
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Data collection
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Surgery for a pancreatic cancer
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Institut Paoli-Calmettes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olivier Turrini, MD,PhD
Role: PRINCIPAL_INVESTIGATOR
Institut Paoli-Calmettes
Vincent Moutardier
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique des Hôpitaux de Marseille
Jean HARDWIGSEN
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique des Hôpitaux de Marseille
Mehdi Ouassi
Role: PRINCIPAL_INVESTIGATOR
Assistance Publique des Hôpitaux de Marseille
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Paoli Calmettes
Marseille, Bouches du Rhone, France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
De Crignis L, Garnier J, Ewald J, Palen A, Piana G, Izaaryene J, Delpero JR, Turrini O. Preoperative liver arterial conditioning in patients scheduled for a Mayo Clinic class Ia distal pancreatectomy: embolization or ligation? HPB (Oxford). 2023 Apr;25(4):439-445. doi: 10.1016/j.hpb.2023.01.007. Epub 2023 Jan 20.
Palen A, Garnier J, Ewald J, Delpero JR, Turrini O. Readmission after pancreaticoduodenectomy: Birmingham score validation. HPB (Oxford). 2023 Feb;25(2):172-178. doi: 10.1016/j.hpb.2022.08.002. Epub 2022 Aug 20.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CHIRPAN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.